Tezepelumab Reduces Patient-reported Cough and Phlegm Production in Patients With Severe, Uncontrolled Asthma: Results From the Phase 3 NAVIGATOR Study

被引：0
|
作者：
Castro, M. [1 ]
Kraft, M. [2 ]
Ambrose, C. S. [3 ]
Martin, N. [4 ,5 ]
Clarke, N. [6 ]
Spahn, J. D. [7 ]
Llanos, J. [8 ]
Ponnarambil, S. [9 ]
机构：
[1] Univ Kansas, Div Pulm Crit Care & Sleep Med, Kansas City, KS USA
[2] Icahn Sch Med Mt Sinai, Dept Med, New York, NY USA
[3] AstraZeneca, BioPharmaceut Med, Resp & Immunol, Gaithersburg, MD USA
[4] AstraZeneca, BioPharmaceut R&D, Biometr Late Stage Dev Resp & Immunol, Waltham, MA USA
[5] Cytel, Waltham, MA USA
[6] AstraZeneca, Patient Ctr Sci Resp & Immunol, Gaithersburg, MD USA
[7] AstraZeneca, BioPharmaceut Med, Resp & Immunol, Wilmington, DE USA
[8] Amgen Inc, Global Med Affairs, Thousand Oaks, CA USA
[9] AstraZeneca, BioPharmaceut R&D, Late Stage Dev Resp & Immunol, Cambridge, England
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4752
引用
收藏
页数：2
相关论文
共 50 条
  • [1] TEZEPELUMAB PRODUCES CLINICALLY MEANINGFUL RESPONSES ON PATIENT-REPORTED OUTCOME MEASURES IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA: RESULTS FROM THE PHASE 3 NAVIGATOR STUDY
    Lugogo, Njira
    Ponnarambil, Sandhia
    Ambrose, Christopher
    Cook, William
    Hunter, Gillian
    Llanos-Ackert, Jean-Pierre
    Corren, Jonathan
    [J]. CHEST, 2021, 160 (04) : 44A - 47A
  • [2] Efficacy of Tezepelumab in Patients With Severe, Uncontrolled Asthma by Sex: Results From the Phase 3 Navigator Study
    Kraft, M.
    Chupp, G. L.
    Reeh, K.
    Lindsley, A. W.
    Cook, B.
    Hunter, G.
    Ambrose, C. S.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [3] Tezepelumab Reduces Exacerbations Across All Seasons in Patients with Severe, Uncontrolled Asthma: Results from the Phase 3 NAVIGATOR Study
    Hoyte, Flavia
    Martin, Neil
    Kmita, Kamil
    Roseti, Stephanie
    Llanos-Ackert, Jean-Pierre
    Lindsley, Andrew
    Colice, Gene
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB63 - AB63
  • [4] Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma with Respiratory Comorbidities: Results from the Phase 3 NAVIGATOR Study
    Carr, Tara
    Bernstein, Jonathan
    Cook, Bill
    Hunter, Gillian
    Ambrose, Chris
    Llanos-Ackert, Jean-Pierre
    Lindsley, Andrew
    Colice, Gene
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB152 - AB152
  • [5] Tezepelumab Reduces Exacerbations Across All Seasons In Patients With Severe, Uncontrolled Asthma With Seasonal Allergy: Results From The Phase 3 NAVIGATOR Study
    Corren, Jonathan
    Lindsley, Andrew
    Spahn, Joseph
    Cook, Bill
    Griffiths, Janet
    Martin, Nicole
    Colice, Gene
    Pavord, Ian
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB194 - AB194
  • [6] Tezepelumab improves patient-reported outcomes in patients with severe, uncontrolled asthma in PATHWAY
    Corren, Jonathan
    Garcia Gil, Esther
    Griffiths, Janet M.
    Parnes, Jane R.
    van der Merwe, Rene
    Salapa, Kinga
    O'Quinn, Sean
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 126 (02) : 187 - 193
  • [7] Effect of Tezepelumab on Lung Function in Patients With Severe, Uncontrolled Asthma in the Phase 3 NAVIGATOR Study
    Menzies-Gow, Andrew
    Ambrose, Christopher S.
    Colice, Gene
    Hunter, Gillian
    Cook, Bill
    Molfino, Nestor A.
    Llanos, Jean-Pierre
    Israel, Elliot
    [J]. ADVANCES IN THERAPY, 2023, 40 (11) : 4957 - 4971
  • [8] EFFECT OF TEZEPELUMAB ON LUNG FUNCTION IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA IN THE PHASE 3 NAVIGATOR STUDY
    Israel, Elliot
    Menzies-Gow, Andrew
    Colice, Gene
    Ambrose, Christopher
    Hunter, Gillian
    Cook, William
    Molfino, Nestor
    Llanos-Ackert, Jean-Pierre
    [J]. CHEST, 2021, 160 (04) : 41A - 43A
  • [9] Efficacy and Safety of Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma: Results from the Phase 3 NAVIGATOR Study
    Menzies-Gow, Andrew
    Corren, Jonathan
    Bourdin, Arnaud
    Chupp, Geoffrey
    Israel, Elliot
    Griffiths, Janet
    Hellqvist, Asa
    Bowen, Karin
    Kaur, Primal
    Almqvist, Gun
    Ponnarambil, Sandhia
    Colice, Gene
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB249 - AB249
  • [10] Effect of Tezepelumab on Lung Function in Patients With Severe, Uncontrolled Asthma in the Phase 3 NAVIGATOR Study
    Andrew Menzies-Gow
    Christopher S. Ambrose
    Gene Colice
    Gillian Hunter
    Bill Cook
    Nestor A. Molfino
    Jean-Pierre Llanos
    Elliot Israel
    [J]. Advances in Therapy, 2023, 40 : 4957 - 4971
12345